Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
9,16 USD | -1,40% | -2,55% | +15,08% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 1,02 mld. 954 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -195 mln. -183 mln. | Nettowinst (verlies) 2025 * | -209 mln. -196 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 92,93 mln. 87,11 mln. | Nettoliquiditeiten 2025 * | 93,52 mln. 87,67 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-5,03
x | K/w-verhouding 2025 * |
-5,29
x | Werknemers | 76 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 88,4% |
Recentste transcriptie over Centessa Pharmaceuticals plc
1 dag | -1,40% | ||
1 week | -2,55% | ||
1 maand | -18,94% | ||
3 maanden | +11,84% | ||
6 maanden | +39,42% | ||
Lopend jaar | +15,08% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Saurabh Saha
CEO | Chief Executive Officer | 47 | 01-01-21 |
Director of Finance/CFO | 53 | 01-03-21 | |
Ellie Im
CTO | Chief Tech/Sci/R&D Officer | - | 03-10-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 61 | 23-02-21 | |
Chairman | 54 | 01-11-20 | |
Brett Zbar
BRD | Director/Board Member | 51 | 01-01-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.02% | 0 M€ | 0,00% | - | |
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
30-04-24 | 9,16 | -1,40% | 141 262 |
29-04-24 | 9,29 | +4,15% | 152 754 |
26-04-24 | 8,92 | -0,11% | 254 924 |
25-04-24 | 8,93 | -5,60% | 286 596 |
24-04-24 | 9,46 | +0,64% | 2 251 501 |
uitgestelde koers Nasdaq, 30 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,08% | 1,02 mld. | |
+0,17% | 42,19 mld. | |
+10,92% | 42,24 mld. | |
+44,30% | 40,15 mld. | |
-6,20% | 28,31 mld. | |
+5,23% | 24,63 mld. | |
-24,79% | 18,2 mld. | |
+26,69% | 12,01 mld. | |
-3,13% | 11,76 mld. | |
+6,57% | 10,4 mld. |